Quarterly report pursuant to Section 13 or 15(d)

NOTE 18: SUBSEQUENT EVENTS (Details)

v3.19.2
NOTE 18: SUBSEQUENT EVENTS (Details)
6 Months Ended
Jun. 30, 2019
Event 1  
Subsequent Event, Date Jul. 02, 2019
Subsequent Event, Description AXIM Biotechnologies, Inc. (“AXIM”) entered into a multi-term, non-exclusive license and distribution agreement (“Agreement”)
Event 2  
Subsequent Event, Date Jul. 11, 2019
Subsequent Event, Description Company has issued 687,285 shares of its restricted common stock to Kettner Investment LLC
Event 3  
Subsequent Event, Date Aug. 01, 2019
Subsequent Event, Description Company has issued 6,055 shares of its restricted stock to Advisory Board